<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Centerin (SERPINA9/GCET1) is a <z:chebi fb="0" ids="37670">protease inhibitor</z:chebi> with expression restricted to germinal center B cells and lymphoid <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> with germinal center B-cell maturation </plain></SENT>
<SENT sid="1" pm="."><plain>Expression of the centerin gene transcript, along with bcl-6 and GCET2/HGAL, constitutes a molecular signature associated with a good prognosis in diffuse large B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>A monoclonal antibody to centerin was generated and used for Western blotting, immunohistochemistry, and immunofluorescence </plain></SENT>
<SENT sid="3" pm="."><plain>Centerin expression was demonstrated in Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> Raji cells </plain></SENT>
<SENT sid="4" pm="."><plain>An immunohistochemical survey of <z:mpath ids='MPATH_458'>normal</z:mpath> tissues showed centerin expression in germinal center B cells in lymphoid follicles in tonsil, lymph node, and lymphoid tissue in the gastrointestinal tract </plain></SENT>
<SENT sid="5" pm="."><plain>Centerin was strongly expressed in most follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>In addition, 14 (47%) of 30 diffuse large B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> were positive for centerin, which correlated most closely with CD10 expression </plain></SENT>
<SENT sid="7" pm="."><plain>Immunohistochemical expression of centerin further defines the germinal center cell origin of a subgroup of <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
</text></document>